|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.83 USD | +1.85% |
|
+4.99% | +36.00% |
| Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
| Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Avid Bioservices, Inc. reiterated revenue guidance for full fiscal year 2024. For the period, the company expects revenue to be between $145 million and $165 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +36.00% | 550M | |
| -2.35% | 89.08B | |
| +2.76% | 40.9B | |
| -13.48% | 32.25B | |
| +54.31% | 25.14B | |
| -15.76% | 15.39B | |
| -8.42% | 11.91B | |
| -41.29% | 11.89B | |
| -12.82% | 11.64B | |
| +7.27% | 9.03B |
AVID BIOSERVICES, INC. 
